首页> 美国卫生研究院文献>other >Discordant financial conflicts of interest disclosures between clinical trial conference abstract and subsequent publication
【2h】

Discordant financial conflicts of interest disclosures between clinical trial conference abstract and subsequent publication

机译:临床试验会议摘要和后续出版物之间的不一致的财务利益冲突披露

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundFinancial conflicts of interest (FCOI) are known to be prevalent in medicine. Authorship of pivotal trials reap non-financial benefits including publication productivity that can be used for assessment of tenure positions and promotion. The purpose of this investigation was to quantify the prevalence and discordance of academic trial author (authors) FCOI in industry-sponsored drug trials that were initially presented as oral abstracts and subsequently resulted in a peer-reviewed publication.
机译:背景技术金融利益冲突(FCOI)在医学中很普遍。关键性试验的作者获得非财务利益,包括出版业生产力,可用于评估任职职位和晋升。这项研究的目的是量化行业赞助的药物试验中学术试验作者(作者)FCOI的患病率和不协调性,这些试验最初以口头摘要形式提交,随后产生了同行评审的出版物。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号